People with multiple sclerosis (MS) are being sought to take part in a study that aims to investigate the benefits of a robotic walking device. Read more…
Rex Bionics is the pioneer of the REX® robotic rehabilitation device that provides standing, walking and exercise support for people with lower limb weakness or paralysis; and is used by people who have suffered a spinal cord injury, stroke, traumatic brain injury or other neurological condition such as multiple sclerosis. Rex Bionics has worked with [...]
Research team AIN-Rehab in collaboration with The University of Newcastle, Australia now has ethics approval to expand the HELLEN research trial using REX to include people living with Multiple Sclerosis. AIN-Rehab continue to work towards the goal of expanding research into the merits of REX for all neurological conditions.
Ethics Committee Approval from NHS’s National Institute for Health Research (NIHR) Partnership with East Kent Hospitals University NHS Foundation Trust, and Kent University Rex Bionics Plc (AIM: RXB), is pleased to announce that the ethics committee of the UK NHS’s National Institute for Health Research has approved the start of a clinical trial to evaluate [...]
Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, is pleased to announce the start of a new clinical trial treating patients who have had a stroke or brain injury, with Robot-Assisted Physiotherapy with REX. The trial is being conducted by the Australian Institute of [...]